Navigation Links
Positive Results from Phase 2 Trial of Mesoblast's Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
Date:11/14/2011

ORLANDO, Florida and MELBOURNE, Australia, November 14, 2011 /PRNewswire/ --

 

  • Revascor™, Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) product for cardiovascular diseases, was safe and well-tolerated at all doses, with no clinically relevant immune responses to donor cells
  • Revascor™ therapy significantly reduced cardiac mortality and major adverse cardiac events (MACE) in patients with congestive heart failure over a mean follow-up of 22 months
  • Highest dose of Revascor™ completely prevented any episodes of heart failure hospitalization over 18 months of follow-up
  • Clinical improvement was associated with evidence of remodeling (reduction in heart volumes) and improvement in functional capacity (increased walking distance), which are key parameters in congestive heart failure
  • Revascor™ anticipated to progress to Phase 3 trial in first half of 2012

Regenerative medicine company Mesoblast Limited (ASX:MSB; OTC ADR:MBLTY) today announced positive Phase 2 heart failure trial results of its allogeneic, or off-the-shelf, adult stem cell product Revascor™ after all patients had completed a minimum follow-up of 12 months, and a mean follow-up of 22 months. The Phase 2 trial results were presented at the American Heart Association annual meeting in Orlando, Florida, by the trial's independent principal investigator Dr Emerson C. Perin, Director of Research in Cardiovascular Medicine and Medical Director, Stem Cell Center, Texas Heart Institute in Houston.

MPC treatment pooled across all doses resulted in significant reduction in cardiac mortality, and at the highest dose resulted in complete preven
'/>"/>

SOURCE Mesoblast
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
2. Ampio Pharmaceuticals Announces Positive Results on Ampion™ Trial for Relief of Nasal Inflammation
3. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
4. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
5. NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinsons Disease
6. Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System
7. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
8. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
9. Positive Phase 2b Results with Sarilumab in Rheumatoid Arthritis to be Presented as a Late-Breaking Poster at the 2011 American College of Rheumatology Annual Meeting
10. Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe
11. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- The U.S. Department of Health and Human Services (HHS) ... Case Medical Center Seidman Cancer Center totaling $4.7 million ... care for patients with complex cancer. ... unique model developed at UH to enhance care for ... demonstrated need for high health care utilization.  ...
(Date:7/10/2014)... WEST JORDAN, Utah , July 10, 2014 /PRNewswire/ ... imaging solutions, and MiE America , Inc., a ... systems, have entered into a long-term agreement naming BC ... in the US. MiE and BC ... a strategic agreement to establish BC Technical as the ...
(Date:7/10/2014)... 10, 2014 CVS Caremark Corporation (NYSE: ... approved a quarterly dividend of $0.275 (27.5 cents) per share ... August 1, 2014, to holders of record on July 21, ... Caremark is dedicated to helping people on their path to ... the United States . Through the company,s more ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2
... 2011 In an effort to boost prescription drug ... LLC, to help promote the Didit® – one of ... and confusion of taking prescription medications. (Photo: ... simple device that sticks to any prescription container. Consumers ...
... The U.S. Food and Drug Administration announced today ... of amino-acid products marketed to treat a number of ... Cosmetic Act are met. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... doing business as CHK Nutrition, and NeuroResearch Clinics Inc., ...
Cached Medicine Technology:Rexam Teams with Didit to Enhance Prescription Drug Compliance 2FDA: Minnesota Companies Agree to Halt Sale of Amino-acid Products with Unapproved Claims 2FDA: Minnesota Companies Agree to Halt Sale of Amino-acid Products with Unapproved Claims 3
(Date:7/14/2014)... Dry eyes, contrary to popular opinion, are not ... have pointed out, today’s technology has practically enabled younger and ... result of using laptops and smartphones to go about ... this phenomenon, it has become imperative for people of today ... from having dry eyes, but prevent it from ever happening ...
(Date:7/14/2014)... Sometimes, thinking “inside the box” can be ... first product release, Joyboxx™ - The world’s only hygienic ... , Inventor and CEO, Deborah Semer began designing a ... solution for their ‘toys’ after she realized no such ... , Semer met 30-year industry veteran Phyllis Heppenstall, the ...
(Date:7/14/2014)... NATURALLY, DANNY SEO, a new magazine from ... a Fall issue that hits newsstands nationwide on July ... healthy, natural and good for you life with a ... travel, home, and entertaining all through Danny’s unique point-of-view ... of gimmicky weight loss tips and fluffy celebrity profiles, ...
(Date:7/14/2014)... July 14, 2014 The Cabin Chiang ... its new Alumni Community website – a ... to help them maintain lifelong recovery wherever they live ... providing clients the tools to help them maintain their ... essential part of any reputable treatment programme. As a ...
(Date:7/14/2014)... new analysis has found that rates of testicular cancer ... Hispanic American men, but not among their non-Hispanic counterparts. ... journal of the American Cancer Society, the findings indicate ... of testicular cancer in Hispanic adolescents and young adults, ... cause of this trend. , Testicular cancer is one ...
Breaking Medicine News(10 mins):Health News:Dry Eye Handbook Review | Taking Care of One’s Vision by Using Natural Methods – Vinamy.com 2Health News:Dry Eye Handbook Review | Taking Care of One’s Vision by Using Natural Methods – Vinamy.com 3Health News:Passionate Playground launches Joyboxx 2Health News:Passionate Playground launches Joyboxx 3Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 2Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 3Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 4Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 5Health News:Harris Publications and Danny Seo Launch NATURALLY, DANNY SEO Magazine 6Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 2Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 3Health News:Testicular cancer rates are on the rise in young Hispanic Americans 2
... ... ... ... ...
... For some Canadians, any cut such as from dental work ... they are not hemophiliacs, for some an ordinary bruise can ... elbows and ankles are crippled when bleeding seeps into joints. ... for recovery. Now a team led by McMaster ...
... with communications and recovery for people with disabilities following ... a research paper in the International Journal of ... Katrina and Rita, other natural disasters, and even technological ... serious need for disaster and emergency preparedness for people ...
... of Contemporary Spirituality will take place at the University of ... an astounding 32 sessions and dozens of lectures presenting studies ... around the world. "This is a wide phenomenon that touches ... the academic world and its various disciplines have found it ...
... ... ... Maryland Gov. Martin O’Malley proposes cutting $123 million from Medicaid for the 2011 budget, in ... Todd Eberly, assistant professor of political science and coordinator of public policy studies at ...
... with aura, researchers say , THURSDAY, March 4 (HealthDay News) ... the head may offer relief for some migraine sufferers, researchers ... experience "aura," expand on previous research by using a device ... doctor,s office. , It,s unclear, however, how expensive the treatment ...
Cached Medicine News:Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 2Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 3Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 4Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 5Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 6Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 7Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 8Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 9Health News:Hard to Treat Diseases (HTDS) Collagenna Skin Care Business Model and Chilean Update 10Health News:Genetic cause discovered for rare bleeding disorder 2Health News:Emergency online communities 2Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 2Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 3Health News:New Hope for Migraine Patients 2
Sterile Silicone Oil for Intraocular Application....
Alcon offers medical grade perfluoropropane (SF6) intraocular gases for ophthalmological use....
Silikon 1000 (purified polydimethylsiloxane) is a highly purified long chain polydimethylsiloxane trimethylsiloxy terminated silicone oil. For use as a postoperative retinal tamponade during vitreore...
Round knurled handle, overall length 130 mm....
Medicine Products: